Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.
Yamashita, M; Iwata, A; Kato, Y; Futami, M; Imaizumi, S; Kuwano, T; Ike, A; Sugihara, M; Nishikawa, H; Zhang, B; Yasunaga, S; Saku, K; Miura, S.I
Heart Vessels, 2018年04月25日, 33(10):1175 - 1184, 査読有り

Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins
Yuta Kato; Atsushi Iwata; Makito Futami; Motoki Yamashita; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Medicine (United States), 2018年04月01日, 97(17):e0589, 査読有り

循環器疾患の疫学、危険因子
瀬川波子; 朔啓二郎; 北島研; 三浦伸一郎
医学生のための循環器内科学テキスト 第5版, 2018年04月01日

２型糖尿病合併する冠動脈疾患患者におけるDPP-4阻害薬シタグリプチンの冠動脈プラークへの効果－血管内超音波を使用した検討－
岩田敦; 加藤悠太; 張波; 桑野孝志; 池周而; 杉原充; 西川宏明; 三浦伸一郎; 安永晋一郎; 朔啓二郎
Research, 2017年, 22(3):15 - 18

Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs).
Yasunaga S; Ohno Y; Shirasu N; Zhang B; Suzuki-Takedachi K; Ohtsubo M; Takihara Y
Int. J. Hematol., 2016年07月15日, 104(3):324 - 329, 査読有り

食の多様性を追求する
朔啓二郎; 三浦伸一郎; 小川正浩; 瀬川波子; 野田慶太; 中嶋恵美子; 安永晋一郎; 柳瀬敏彦; 西尾美登里
日本機能性食品医用学会誌, 2016年06月, 10(1):397 - 406, 査読有り

Impact of cigarette smoking cessation on high-density lipoprotein functionality.
高田 耕平; 今泉 聡; 川内 絵未; 末松 保憲; 野田 慶太; 八尋 英二; 瀬川 波子; 上原 吉就; 三浦 伸一郎; 朔 啓二郎
Circ J., 2014年, 査読有り

Therapeutic approaches to the regulation of HDL metabolism. -Novel HDL-directed pharmacological intervention and exercise-
瀬川 波子; 黒木 政秀
Circ. J., 2013年, 77(11):2651 - 2663, 査読有り

FLAVO Study を紹介する：内臓肥満には大豆蛋白か乳蛋白か？ Introduction of FLAVO Study : soy protein or milk protein?, for visceral fat obesity.
野田慶太; 高比良誠也; 瀬川波子; 朔啓二郎
日本内科学会雑誌, 2013年, 102(8):2087 - 2092

研究機関研究所近況 産学官連携研究機関 心臓・血管研究所 魚消費と院外心停止の関連について．
末松保憲; 上原吉就; 三浦伸一郎; 瀬川波子; 朔啓二郎
Research, 2013年, 18(1):38 - 40

Lifestyle changes through the use of delivered meals and dietary counseling in a single-blind study -the STYLIST Study- の紹介．
朔啓二郎; 野田慶太; 瀬川波子; 柳瀬敏彦
Research, 2012年, 17(3):22 - 25

Lifestyle changes through the use of delivered meals and dietary counseling in a single-blind study - the STYLIST Study- ．
朔啓二郎; 野田慶太; 瀬川波子; 柳瀬敏彦
日本内科学会雑誌, 2012年, 101(7):2094 - 2095

第6回循環器疾患治療研究会 「実地医家主導の臨床研究推進の在り方」
朔啓二郎; 大賀正継; 古井宏彦; 仁位隆信; 瀬川波子; 高田耕基; 野田慶太; 深見良
Vascular Street, 2010年, 5(1):1 - 6

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study
Bo Zhang; Akira Matsunaga; David L. Rainwater; Shin-ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
JOURNAL OF LIPID RESEARCH, 2009年09月, 50(9):1832 - 1841

The impact of angulated lesions on angiographic late loss in patients with drug-eluting stent implantation
Yusuke Fukuda; Kazuyuki Shirai; Shinichiro Miura; Amane Ike; Yosuke Takamiya; Takashi Kuwano; Daizaburo Yanagi; Ken Mori; Kazumitsu Kubota; Nathan Miller; Hiroaki Nishikawa; Bo Zhang; Keijiro Saku
JOURNAL OF CARDIOLOGY, 2009年06月, 53(3):396 - 401

Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease
Yosuke Takamiya; Shin-Ichiro Miura; Akira Kawamura; Hiroyuki Tanigawa; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Kunihiro Matsuo; Kazuyuki Shirai; Keijiro Saku
CORONARY ARTERY DISEASE, 2009年06月, 20(4):288 - 294

［用語解説］ 陰性荷電LDL(LDL-またはcITP fLDL)
瀬川波子; 朔啓二郎
循環器専門医, 2009年, 17(1):161

Significance of Urinary Liver-fatty Acid-binding Protein in Cardiac Catheterization in Patients with Coronary Artery Disease
Yusuke Fukuda; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Kazuyuki Shirai; Keijiro Saku
INTERNAL MEDICINE, 2009年, 48(19):1731 - 1737

Genotypic Effect of ABCG1 gene promoter -257T>G polymorphism on coronary artery disease severity in Japanese men.
Furuyama S; Uehara Y; Zhang B; Baba Y; Abe S; Iwamoto T; Miura S; Saku K
J Atheroscler Thromb., 2009年, 16:194 - 200

Positive association between benign familial infantile convulsions and LGI4.
Ishii A; Zhang B; Kaneko S; Hirose S
Brain Dev., 2009年

Expression of Human ApoAII in Transgenic Rabbits Leads to Dyslipidemia: A New Model for Combined Hyperlipidemia.
Koike T; Kitajima S; Yu Y; Li Y; Nishijima K; Liu E; Sun H; Waqar AB; Shibata N; Inoue T; Wang Y; Zhang B; Kobayashi J; Morimoto M; Saku K; Watanabe T; Fan J
Arterioscler Thromb Vasc Biol., 2009年, 29:2047 - 2053

HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography.
Mitsutake R; Miura SI; Zhang B; Saku K
Int J Cardiol., 2009年

A Postmenopausal Patient with Tangier Disease Developing Sjogren's Syndrome
Kiyomitsu Miyachi; Raleigh W. Hankins; Yoshinari Uehara; Bo Zhang; Keijiro Saku; Yasuhiko Homma; Hiroshi Shigematsu; Katsuhiko Mikoshiba
JOURNAL OF RHEUMATOLOGY, 2009年01月, 36(1):208 - 210

家族性高コレステロール血症患者におけるシンバスタチン単独投与とエゼチミブ併用の動脈硬化進展に及ぼす効果.
張波; 朔啓二郎
循環器専門医., 2009年, 26:862

Reduction of charge-modified LDL by statin therapy in patients with CHD or CHD risk factors and elevated LDL-C levels: The SPECIAL Study
Bo Zhang; Shin-ichiro Miura; Daizaburo Yanagi; Keita Noda; Hiroaki Nishikawa; Akira Matsunaga; Kazuyuki Shirai; Atsushi Iwata; Kazuhiko Yoshinaga; Hisashi Adachi; Tsutomu Imaizumi; Keijiro Saku
ATHEROSCLEROSIS, 2008年12月, 201(2):353 - 359

Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats
Satoshi Imaizumi; Shin-ichiro Miura; Kazuto Nakamura; Yoshihiro Kiya; Yoshinari Uehara; Bo Zhang; Yoshino Matsuo; Hidenori Urata; Munehito Idelshi; Kerry-Anne Rye; Masataka Sata; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008年04月, 51(16):1604 - 1612

Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: Multicenter study in Japan
Daizaburo Yanagi; Kazuyuki Shirai; Yosuke Takamiya; Yusuke Fukuda; Takashi Kuwano; Amane Ike; Ken Mori; Kazumitsu Kubota; Atsushi Iwata; Kanta Fujimi; Akira Kawamura; Hiroaki Nishikawa; Nathan Miller; Bo Zhang; Yoshihiro Tsuchiya; Hidenori Urata; Keijiro Saku
JOURNAL OF CARDIOLOGY, 2008年04月, 51(2):89 - 94

POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease
Yoshinari Uehara; Yoshio Tsuboi; Bo Zhang; Shin-ichiro Miura; Yasuhiko Baba; Masa-aki Higuchi; Tatsuo Yamada; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, 2008年03月, 197(1):283 - 289

A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy
Masahiro Hagiwara; Kunihiro Yamagata; Tsuneaki Matsunaga; Yoh Arakawa; Joichi Usui; Yoshio Shimizu; Kumi Aita; Michio Nagata; Akio Koyama; Bo Zhang; Akira Mastunaga; Keigiro Saku; Takao Saito
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008年01月, 23(1):381 - 384, 査読有り

高比重リポ蛋白（HDL)治療の確立
上原吉就; 瀬川波子; 松尾邦浩; 西川宏明; 三浦伸一郎; 朔啓二郎
Research, 2008年, 13(1):31 - 33

総合内科専門医の育成のために 臨床医学研究と総合内科専門医
朔啓二郎; 瀬川波子; 細井薫
日本内科学会雑誌, 2008年, 97(10):2590 - 2595

A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy
Masahiro Hagiwara; Kunihiro Yamagata; Tsuneaki Matsunaga; Yoh Arakawa; Joichi Usui; Yoshio Shimizu; Kumi Aita; Michio Nagata; Akio Koyama; Bo Zhang; Akira Mastunaga; Keigiro Saku; Takao Saito
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008年01月, 23(1):381 - 384

Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study
Yoshihito Inoue; Bo Zhang; Riko Sadamori; Kyoko Shirota; Keijiro Saku; Tatsuhiko Kawarabayashi
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008年01月, 15(1):157 - 163

Strong linkage disequilibrium and association of-1131T > C and c.553G > T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population
Akira Matsunaga; Hiroaki Arishima; Hideya Niimura; Bo Zhang; Yoshinari Uehara; Kazuo Ohwaki; Mie Morita; Kazue Hayashida; Keijiro Saku
CIRCULATION JOURNAL, 2007年05月, 71(5):746 - 752

Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis
Bo Zhang; Yoshinari Uehara; Satoru Hida; Shin-ichiro Miura; David L. Rainwater; Masaru Segawa; Koichiro Kumagai; Kerry-Anne Rye; Keijiro Saku
JOURNAL OF LIPID RESEARCH, 2007年05月, 48(5):1175 - 1189

Control of matrix effects in the analysis of urinary F2- isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS
Bo Zhang; Keijiro Saku
Journal of Lipid Research, 2007年03月, 48(3):733 - 744

Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels
Bo Zhang; Alfred Boettcher; Satoshi Imaizumi; Keita Noda; Gerd Schmitz; Keijiro Saku
ATHEROSCLEROSIS, 2007年03月, 191(1):153 - 161

Do valsartan and losartan have the same effects in the treatment of coronary artery disease?
Iwata A; Miura S; Imaizumi S; Kiya Y; Nishikawa H; Zhang B; Shimomura H; Kumagai K; Matsuo K; Shirai K; Saku K
Circ J., 2007年, 71:32 - 38

Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound.
Iwata A; Miura S; Imaizumi S; Zhang B; Saku K
J Cardiol., 2007年, 50:229 - 234

Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
Circ J., 2007年, 71:214 - 219

Possible predictors of target lesion revascularization after drug-eluting stent implantation
Daizaburo Yanagi; Kazuyuki Shirai; Ken Mori; Amane Ike; Costantino O. Costantini; Costantino R. Costantini; Hiroaki Nishikawa; Nathan Miller; Bo Zhang; Yoshihiro Tsuchiya; Hidenori Urata; Keijiro Saku
Journal of Cardiology, 2007年, 49(2):63 - 67

Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS.
Zhang B; Saku K
J Lipid Res., 2007年, 48:733 - 744

Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism
Yoshihiro Kiya; Shin-ichiro Miura; Bo Zhang; Hidenori Urata; Keijiro Saku
ENDOCRINE JOURNAL, 2006年12月, 53(6):865 - 868

Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis
Bo Zhang; Ritsuko Katafuchi; Hiroaki Arishima; Akira Matsunaga; Kerry-Anne Rye; Keijiro Saku
CLINICA CHIMICA ACTA, 2006年11月, 373(1-2):55 - 61

Low-density lipoprotein oxidized to various degrees activates ERK 1/2 through Lox-1
Hiroyuki Tanigawa; Shin-ichiro Miura; Bo Zhang; Yoshinari Uehara; Yoshino Matsuo; Masahiro Fujino; Tatsuya Sawamura; Keijiro Saku
ATHEROSCLEROSIS, 2006年10月, 188(2):245 - 250

ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis
Bo Zhang; Shin-ichiro Miura; Ping Fan; Koichiro Kumagai; Kazuma Takeuchi; Yoshinari Uehara; Monica McMahon; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, 2006年09月, 188(1):95 - 101

Association between fast-migrating low-density lipoprotein subfraction as characterized by capillary isotachophoresis and intima-media thickness of carotid artery
Bo Zhang; Naoyasu Maeda; Kyoko Okada; Masafumi Tatsukawa; Yasumori Sawayama; Akira Matsunaga; Koichiro Kumagai; Shin-ichiro Miura; Takamitsu Nagao; Jun Hayashi; Keijiro Saku
ATHEROSCLEROSIS, 2006年07月, 187(1):205 - 212

Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration
B Zhang; P Fan; E Shimoji; H Itabe; S Miura; Y Uehara; A Matsunaga; K Saku
ATHEROSCLEROSIS, 2006年06月, 186(2):291 - 301

Changes in total lipid profiles assessed by analytical capillary isotachophoresis throughout the acute phase of myocardial infarction
K Okamura; SI Miura; B Zhang; H Nishikawa; K Matsuo; K Shirai; K Sak-U
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006年04月, 108(2):264 - 266

Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease
S Imaizumi; S Miura; H Nishikawa; A Iwata; B Zhang; A Kawamura; Y Tsuchiya; K Kumagai; K Matsuo; K Saku
HYPERTENSION RESEARCH, 2006年03月, 29(3):135 - 141

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
河村 彰; 新村 英也; 三浦 伸一郎; 瀬川 波子; 岩田 敦; 西川 宏明; 熊谷 浩一郎; 白井 和之; 松永 彰; 朔 啓二郎
Circ J, 2006年

Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
今泉 聡; 三浦 伸一郎; 西川 宏明; 岩田 敦; 瀬川 波子; 河村 彰; 土屋 芳弘; 熊谷 浩一郎; 松尾 邦浩; 朔 啓二郎
Hypertens Res., 2006年

Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction.
岩田 敦; 三浦 伸一郎; 白井 和之; 河村 彰; 瀬川 波子; 西川 宏明; 熊谷 浩一郎; 松尾 邦浩; 朔 啓二郎
2006年

Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction
Atsushi Iwata; Shin-ichiro Miura; Kazuyuki Shirai; Akira Kawamura; Sayo Tomita; Yoshino Matsuo; Bo Zhang; Hiroaki Nishikawa; Koichiro Kumagai; Kunihiro Matsuo; Keijiro Saku
INTERNAL MEDICINE, 2006年, 45(15):885 - 890

New approach to pulmonary vein isolation for atrial fibrillation using a multielectrode basket catheter.
Kumagai K; Noguchi H; Ogawa M; Nakashima H; Zhang B; Miura S; Saku K
Circ J., 2006年, 70:88 - 93

Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients.
Mitsutake R; Niimura H; Miura S; Zhang B; Iwata A; Nishikawa H; Kawamura A; Kumagai K; Shirai K; Matsunaga A; Saku K
Circ J., 2006年, 70:1122 - 1127

Relation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresis
B Zhang; T Kaneshi; T Ohta; K Saku
JOURNAL OF LIPID RESEARCH, 2005年10月, 46(10):2265 - 2277

Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice
B Zhang; N Shono; P Fan; S Ando; HL Xu; S Jimi; S Miura; K Kumagai; KM Win; A Matsunaga; H Iwasaski; K Saku
HYPERTENSION RESEARCH, 2005年08月, 28(8):681 - 688

Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis
Hiroaki Nishikawa; Shin-Ichiro Miura; Hideki Shimomura; Kenichi Tsujita; Keisuke Okamura; Bo Zhang; Atsushi Iwata; Kazuyuki Shirai; Kunihiro Matsuo; Hidekazu Arai; Keijiro Saku
Journal of Cardiology, 2005年03月, 45(3):107 - 113

A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia
B Zhang; K Noda; A Matsunaga; K Kumagai; K Saku
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2005年02月, 12(1):41 - 47

Comparison of 2 mapping strategies for pulmonary vein isolation.
Kumagai K; Ogawa M; Noguchi H; Nakashima H; Zhang B; Miura S; Saku K
Circ J., 2005年, 69:1496 - 1502

Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction.
Noda K; Zhang B; Uehara Y; Miura S; Matsunaga A; Saku K
Circ J., 2005年, 69:1568 - 1570

C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance.
Sun H; Koike T; Ichikawa T; Hatakeyama K; Shiomi M; Zhang B; Kitajima S; Morimoto M; Watanabe T; Asada Y; Chen YE; Fan J
Am J Pathol., 2005年, 167:1139 - 1148

Hybrid therapy with pilsicainide and pulmonary vein isolation for atrial fibrillation.
Tojo H; Kumagai K; Noguchi H; Ogawa M; Yasuda T; Nakashima H; Zhang B; Miura S; Saku K
Circ J., 2005年, 69:1503 - 1507

Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins
Bo Zhang; Hideaki Tomura; Atsushi Kuwabara; Takao Kimura; Shin-Ichiro Miura; Keita Noda; Fumikazu Okajima; Keijiro Saku
Atherosclerosis, 2005年01月, 178(1):199 - 205

Influence of age and hypertension on the association between small artery compliance and coronary artery disease
K Takeuchi; B Zhang; M Ideishi; H Urata; K Noda; T Tashiro; M Kimura; K Saku
AMERICAN JOURNAL OF HYPERTENSION, 2004年12月, 17(12):1188 - 1191

Effects of the Na+ channel blocker pilsicainide on the electrophysiologic properties of pulmonary veins in patients with atrial fibrillation
K Kumagai; H Tojo; H Noguchi; T Yasuda; M Ogawa; H Nakashima; B Zhang; K Saku
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004年11月, 15(12):1396 - 1401

Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins
Y Okura; M Takao; B Zhang; Y Nakashima; K Saku
HYPERTENSION RESEARCH, 2004年10月, 27(10):723 - 729

Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits
B Zhang; P Fan; E Shimoji; HL Xu; K Takeuchi; C Bian; K Saku
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004年10月, 24(10):1910 - 1915

難治性ネフローゼ症候群に対するLDLアフェレーシス（LDL-A）療法の効果. キャピラリー等速電気泳動（cITP）法による解析
安部泰弘; 小河原悟; 笹冨佳江; 村田敏晃; 兼岡秀俊; 斉藤喬雄; 張波; 朔啓二郎
Therapeutic Research, 2004年09月, 25(9):1822 - 1824, 査読有り

Simple and rapid detection of uncoupling protein-2-866G/A polymorphism by mutagenically separated polymerase chain reaction
B Zhang; H Tanaka; K Saku
CLINICA CHIMICA ACTA, 2004年06月, 344(1-2):205 - 210

T13M mutatioin of lecithin-cholesterol acyltransferase gene causes fish-eye disease
T Miida; B Zhang; K Obayashi; U Seino; Y Zhu; T Ito; Y Nakamura; M Okada; K Saku
CLINICA CHIMICA ACTA, 2004年05月, 343(1-2):201 - 208

Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men
B Zhang; H Bai; R Liu; K Kumagai; H Itabe; T Takano; K Saku
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004年04月, 53(4):423 - 429

Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB)
G Fukuma; H Oguni; T Shirasaka; K Watanabe; T Miyajima; S Yasumoto; M Ohfu; T Inoue; A Watanachai; R Kira; M Matsuo; T Muranaka; F Sofue; B Zhang; S Kaneko; A Mitsudome; S Hirose
EPILEPSIA, 2004年02月, 45(2):140 - 148

Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits
E Shimoji; B Zhang; P Fan; K Saku
ATHEROSCLEROSIS, 2004年02月, 172(2):247 - 257

Pitavastatin, a potent hydroxymethylglutaryl coenzyme a reductase inhibitor, increases cholesterol 7 alpha-hydroxylase gene expression in HepG2 cells.
Fan P; Zhang B; Kuroki S; Saku K
Circ J., 2004年, 68:1061 - 1066

Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis.
Kawamura A; Miura S; Murayama T; Iwata A; Zhang B; Nishikawa H; Tsuchiya Y; Matsuo K; Tsuji E; Saku K
Circ J., 2004年, 68:6 - 10

Statins induce the regression of left ventricular mass in patients with angina.
Nishikawa H; Miura S; Zhang B; Shimomura H; Arai H; Tsuchiya Y; Matsuo K; Saku K
Circ J., 2004年, 68:121 - 125

Associations among plasma lipoprotein subfractions as characterized by analytical capillary isotachophoresis, apolipoprotein E phenotype, Alzheimer disease, and mild cognitive impairment.
Zhang B; Matsunaga A; Saku K; Nakano S; Yamada T
Arterioscler Thromb Vasc Biol., 2004年, 24:e144 - 146

Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis
B Zhang; S Eto; P Fan; C Bian; E Shimoji; T Saito; K Saku
CLINICAL NEPHROLOGY, 2003年10月, 60(4):257 - 265

LDLアフェレーシスにおけるキャピラリー等速電気泳動（cITP）法による全リポ蛋白プロフィールの分析.
小河原悟; 野田律矢; 村田敏晃; 兼岡秀俊; 斉藤喬雄; 張波; 朔啓二郎
Therapeutic Research, 2003年07月, 24(7):1257 - 1259, 査読有り

Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods
B Zhang; E Shimoji; H Tanaka; K Saku
LIPIDS, 2003年03月, 38(3):209 - 218

The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle
B Zhang; H Tanaka; N Shono; S Miura; A Kiyonaga; M Shindo; K Saku
CLINICAL GENETICS, 2003年02月, 63(2):139 - 144

Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease.
Miura S; Nishikawa H; Zhang B; Matsuo Y; Kawamura A; Tsuchiya Y; Matsuo K; Saku K
Circ J., 2003年, 67:535 - 538

Effect of atorvastatin on total lipid profiles assessed by analytical capillary isotachophoresis
B Zhang; K Noda; K Saku
CARDIOLOGY, 2003年, 99(4):211 - 213

Multivariate analysis of the prognostic determinants of the depressor response to exercise therapy in patients with essential hypertension.
Zhang B; Sakai T; Noda K; Kiyonaga A; Tanaka H; Shindo M; Saku K
Circ J., 2003年, 67:579 - 584

Pravastatin promotes coronary collateral circulation in patients with coronary artery disease
H Nishikawa; S Miura; B Zhang; H Shimomura; H Arai; Y Tsuchiya; K Saku
CORONARY ARTERY DISEASE, 2002年11月, 13(7):377 - 381

Association of angiotensin-converting-enzyme gene polymorphism with the depressor response to mild exercise therapy in patients with mild to moderate essential hypertension
B Zhang; T Sakai; S Miura; A Kiyonaga; H Tanaka; M Shindo; K Saku
CLINICAL GENETICS, 2002年10月, 62(4):328 - 333

末梢動脈硬化とHDL.
張波; 朔啓二郎
Progress in Medicine., 2002年, 22:69 - 73

The associations among thoracic aortic atherosclerosis, coronary atherosclerosis and the function of high density lipoprotein
M Takao; B Zhang; P Fan; J Nomoto; K Saku
ATHEROSCLEROSIS, 2001年12月, 159(2):407 - 416

Effects of high-dose troglitazone on insulin sensitivity and beta-cell function in watanabe heritable hyperlipidemic rabbits
B Zhang; M Shiomi; H Tanaka; J Mei; P Fan; Y Tsujita; H Horikoshi; K Saku
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2001年07月, 26(3):185 - 192

The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction.
Takezako T; Zhang B; Serikawa T; Fan P; Nomoto J; Saku K
Jpn Circ J., 2001年, 65:603 - 609

Angiotensin II type-1 receptor antagonist, CS-866, reduces blood pressure without affecting glucose/insulin metabolism in cholesterol-fed rabbits
B Zhang; P Fan; H Tanaka; K Saku
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2001年, 58(4):217 - 225

HDL代謝からみた冠動脈疾患の臨床スタディ.
張波; 朔啓二郎
循環器科., 2001年, 50:391 - 398

preβ-HDL.
張波; 三井田孝; 朔啓二郎
日本臨床（増刊号） 高脂血症, 上巻., 2001年, 59:Suppl2, 80 - 85

In vivo metabolism of HDL, apo A-I, and lp A-I, and function of HDL--a clinical perspective.
Zhang B; Saku K; Ohta T
J Atheroscler Thromb., 2000年, 7:59 - 66

HMG-CoA還元酵素阻害薬の血清脂質、リポ蛋白、およびアポ蛋白レベルに及ぼす効果の比較試験.
朔啓二郎; 下地栄壮; 范平; 北島研, 張波
臨床と研究., 2000年, 77:183 - 186

高脂血症治療薬の使い方とその留意点.
張波; 自見至郎; 朔啓二郎
内科専門医会誌., 2000年, 12:78 - 82

米国心臓病学会学術集会の紹介.
張波; 熊谷浩一郎; 中島英子; 上原吉就; 古賀敬史; 星野史博; 浦田秀則; 朔啓二郎
内科専門医会誌., 2000年, 12:188 - 193

Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease
K Saku; B Zhang; K Shirai; S Jimi; K Yoshinaga; K Arakawa
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999年11月, 34(5):1443 - 1451

Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell line
K Liu; JF Ou; K Saku; S Jimi; DP Via; JT Sparrow; B Zhang; HJ Pownall; LC Smith; K Arakawa
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999年09月, 19(9):2207 - 2213

A missense mutation of the nitric oxide synthase (eNOS) gene (Glu(298)Asp) in five patients with coronary artery disease - Case reports
YL Liao; K Saku; JF Ou; S Jimi; B Zhang; K Shirai; K Arakawa
ANGIOLOGY, 1999年08月, 50(8):671 - 676

Possible induction of renal dysfunction in patients with lecithin : cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli
S Jimi; N Uesugi; K Saku; H Itabe; B Zhang; K Arakawa; S Takebayashi
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999年03月, 19(3):794 - 801

In vivo kinetics of human apolipoprotein A-I variants in rabbits
K Saku; A von Eckardstein; B Zhang; R Liu; S Jimi; J Ou; T Ohta; G Assmann; K Arakawa
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999年03月, 29(3):196 - 203

Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris
T Takezako; K Saku; B Zhang; JF Ou; H Bai; K Imai; S Jimi; K Shirai; K Arakawa
AMERICAN JOURNAL OF HYPERTENSION, 1999年03月, 12(3):291 - 297

Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis
K Saku; B Zhang; T Ohta; K Arakawa
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999年02月, 33(2):436 - 443

Cholesterol paradox in patients with paroxysmal atrial fibrillation
M Annoura; M Ogawa; K Kumagai; B Zhang; K Saku; K Arakawa
CARDIOLOGY, 1999年, 92(1):21 - 27

Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
Jpn Circ J., 1999年, 63:471 - 477

Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Jpn Circ J., 1999年, 63:659 - 665

Levels of soluble cell adhesion molecules in patients with angiographically defined coronary atherosclerosis.
Saku K; Zhang B; Ohta T; Shirai K; Tsuchiya Y; Arakawa K
Jpn Circ J., 1999年, 63:19 - 24

Insulin resistance and angiographical characteristics of coronary atherosclerosis.
Takezako T; Saku K; Zhang B; Shirai K; Arakawa K
Jpn Circ J., 1999年, 63:666 - 673

High density lipoprotein as an indicator for coronary artery disease.
Saku K; Zhang B
Cardiology Review., 1999年, 17:25 - 30

Pre-βHDL代謝とその機能.
朔啓二郎; 張波
The Lipid., 1999年, 10:264 - 276

Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene
JF Ou; K Saku; S Jimi; T Ohta; B Zhang; HJ Pownall; Y Shimada; Y Tsujita; K Arakawa
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998年07月, 1393(1):153 - 160

高血圧症家族歴と遺伝因子から高血圧運動療法の適応性を探る.
朔啓二郎; 張波; 荒川規矩男
内科専門医会誌., 1998年, 10:194 - 197

長期抗脂血薬投与中の家族性高コレステロール血症ヘテロ接合体の１症例.
朔啓二郎; 自見至郎; 今井紀美子; 張波; 欧加福; 廖遠嵐; 武田由紀子; 荒川規矩男
日本臨床内科医会会誌., 1998年, 13:161 - 164

Mechanism of action of gemfibrozil on HDL metabolism and atherosclerosis in WHHL rabbits
R Liu; K Saku; S Jimi; T Ohta; B Zhang; S Takebayashi; K Arakawa
CARDIOVASCULAR DRUGS AND THERAPY, 1997年11月, 11(5):659 - 668

Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits
K Saku; B Zhang; T Ohta; K Arakawa
AMERICAN JOURNAL OF HYPERTENSION, 1997年09月, 10(9):1027 - 1033

Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in watanabe heritable hyperlipidemic rabbits: A minimal model analysis
B Zhang; K Saku; K Arakawa
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997年03月, 46(3):273 - 281

Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension
K Saku; B Zhang; T Okamoto; Y Takeda; K Liu; S Jimi; K Arakawa
JOURNAL OF HUMAN HYPERTENSION, 1996年04月, 10(4):263 - 268

Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triglyceride lipase in rats
K Saku; T Okamoto; Y Takeda; S Jimi; B Zhang; H Bai; R Liu; K Arakawa
ARTERY, 1996年, 22(1):36 - 48

ビソプロロール、リシノプリル、及び塩酸マニジピンの本態性高血圧患者における血清脂質、QOLに及ぼす効果之検討.
朔啓二郎; 張波; 荒川規矩男
臨床と研究., 1996年, 73:1919 - 1926

HIGH-DENSITY-LIPOPROTEIN AND APOLIPOPROTEIN-A-I DEFICIENCY INDUCED BY COMBINATION THERAPY WITH PROBUCOL AND BEZAFIBRATE
K SAKU; B ZHANG; S JIMI; H BAI; K HIRATA; N SASAKI; R LIU; K ARAKAWA
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995年07月, 48(3-4):209 - 215

QUANTITATIVE CHARACTERIZATION OF INSULIN-GLUCOSE RESPONSE IN WATANABE HERITABLE HYPERLIPIDEMIC AND CHOLESTEROL-FED RABBITS AND THE EFFECT OF CILAZAPRIL
B ZHANG; K SAKU; K HIRATA; R LIU; K TATEISHI; M SHIOMI; K ARAKAWA
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994年03月, 43(3):360 - 366

IN-VITRO CONVERSION OF RECOMBINANT HUMAN PROAPOLIPOPROTEIN A-I TO APOLIPOPROTEIN-A-I
K SAKU; H BAI; K HIRATA; R LIU; B ZHANG; K OHKUBO; K YAMAMOTO; K ARAKAWA
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994年01月, 1217(1):29 - 30

APOLIPOPROTEIN(A) PHENOTYPES AND SERUM LIPOPROTEIN(A) LEVELS IN MAINTENANCE HEMODIALYSIS-PATIENTS WITH WITHOUT DIABETES-MELLITUS
K HIRATA; S KIKUCHI; K SAKU; S JIMI; B ZHANG; S NAITO; H HAMAGUCHI; K ARAKAWA
KIDNEY INTERNATIONAL, 1993年11月, 44(5):1062 - 1070

IN-VIVO KINETICS OF LIPOPROTEIN(A) IN HOMOZYGOUS WATANABE HERITABLE HYPERLIPEMIC RABBITS
R LIU; K SAKU; GM KOSTNER; K HIRATA; B ZHANG; M SHIOMI; K ARAKAWA
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993年09月, 23(9):561 - 565

SERUM LIPOPROTEIN-(A) LEVELS IN MAINTENANCE HEMODIALYSIS-PATIENTS
Y OKURA; K SAKU; K HIRATA; B ZHANG; R LIU; S OGAHARA; S NAITO; G KAJIYAMA; K ARAKAWA
NEPHRON, 1993年09月, 65(1):46 - 50

COMBINED THERAPY WITH PROBUCOL AND PRAVASTATIN IN HYPERCHOLESTEROLEMIA - ONE-YEAR FOLLOW-UP-STUDY
K SAKU; B ZHANG; K HIRATA; Y OKURA; H BAI; R LIU; K ARAKAWA
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993年07月, 44(6):535 - 539

INVIVO KINETICS OF OXIDATIVELY MODIFIED HDL
R LIU; K SAKO; B ZHANG; K HIRATA; M SHIOMI; K ARAKAWA
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993年06月, 49(3):392 - 397

LONG-TERM ADMINISTRATION OF PROBUCOL AND QTC INTERVAL PROLONGATION
N SASAKI; K SAKU; K MOROE; B ZHANG; K HIRATA; R LIU; K ARAKAWA
ARTERY, 1993年, 20(2):115 - 121

EFFECTS OF MANIDIPINE AND DELAPRIL ON SERUM-LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION - A RANDOMIZED TRIAL WITH ONE-YEAR FOLLOW-UP
K SAKU; B ZHANG; K HIRATA; R LIU; N SASAKI; T SAKAI; H YING; K ARAKAWA
CLINICAL THERAPEUTICS, 1992年11月, 14(6):813 - 820

EFFECTS OF CHINESE HERBAL DRUGS ON SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN MILD TO MODERATE ESSENTIAL HYPERTENSIVE PATIENTS
K SAKU; K HIRATA; B ZHANG; R LIU; H YING; Y OKURA; K YOSHINAGA; K ARAKAWA
JOURNAL OF HUMAN HYPERTENSION, 1992年10月, 6(5):393 - 395

本能性高血圧患者における大柴胡湯の血圧及び血清リポ蛋白、アポ蛋白レベルに及ぼす効果.
紅英; 朔啓二郎; 平田恭子; 佐々木伸夫; 劉瑞, 張波; 荒川規矩男
動脈硬化., 1992年, 20:943 - 948

INSULIN RESISTANCE OBSERVED IN WHHL RABBITS
B ZHANG; K SAKU; K HIRATA; R LIU; K TATEISHI; K YAMAMOTO; K ARAKAWA
ATHEROSCLEROSIS, 1991年12月, 91(3):277 - 278

3. 循環器・代謝疾患分子標的グループ
朔啓二郎; 三浦伸一郎; 瀬川波子; 上原吉就; 西川宏明; 小川正浩; 河村彰
先端分子医学研究センター 2010年度年報, 2011年, :121 - 179

モデル・コア・カリキュラム対応 医用生化学 ー生体物質の代謝と異常ー ２０１7年版
安永 晋一郎; 黒木 政秀; 黒木 求; 瀬川 波子; 衣笠 哲史; 芝口 浩智; 白須 直人; 四元 房典, 編者(編著者), 編著
福岡大学医学部生化学講座, 2017年03月31日
9784990942601

モデル・コア・カリキュラム対応 医用生化学 ー生体物質の代謝と異常ー ２０１６年版
安永 晋一郎; 黒木 政秀; 黒木 求; 瀬川 波子; 衣笠 哲史; 芝口 浩智; 白須 直人; 四元 房典, 編者(編著者), 編著
福岡大学医学部生化学講座, 2016年03月31日
9784990314699

モデル・コア・カリキュラム対応 医用生化学 ー生体物質の代謝と異常ー ２０１５年版
安永 晋一郎; 黒木 政秀; 黒木 求; 瀬川 波子; 衣笠 哲史; 芝口 浩智; 白須 直人; 四元 房典, 共著, 編著
福岡大学医学部生化学講座, 2015年03月31日
9784990314682

モデル・コア・カリキュラム対応 医用生化学―生体物質の代謝と異常― 2014年版
黒木 政秀; 黒木 求; 瀬川 波子; 芝口 浩智; 白須 直人; 四元 房典, 編者(編著者)
福岡大学医学部生化学教室, 2014年
9784990314675

モデル・コア・カリキュラム対応 医用生化学―生体物質の代謝と異常― 2013年版
黒木政秀; 瀬川波子; 芝口浩智; 四元房典; 白須直人, 編者(編著者)
福岡大学医学部生化学教室, 2013年
9784990314668

動脈硬化症の新しい診断・治療標的：CETP．
谷川宏之; 張 波; 黒木政秀; 朔啓二郎, 共編者(共編著者), pp. 21-32
メディカルレビュー社, 2012年

The HDL Handbook
Akira Matsunaga; Yoshinari Uehara; Bo Zhang; Keijiro Saku, 分担執筆, 133-151
Elsevier, 2010年

LCATの作用とFERHDLの臨床的意義.
張波; 朔啓二郎, 共著, 117-121
2002年

Association between insertion / deletion polymorphism of the angiotensin I converting enzyme gene and blood pressure response to exercise in normal and hypertensive patients.
Kiyonaga A; Imai K; Zhang B; Saku K, 共著, 35-44
1999年

Charge-modified low-density lipoprotein is associated with progression aortic stiffness in hemodialysis patients
Abe Y; Ito K; Ogahara S; Sasatomi Y; Nakashima H; Zhang B; Saku K; Saito T
WCN 2013 Satellite Symposium "Kidney and Lipids", 2013年06月06日

HDL-raising efficacy and the effects of ROSuvastatin on small, dense electronegative LDL as characterized by capillARY isotachophoresis: the ROSARY study.
Zhang B; Matsunaga A; Miura SI; Noda K; Nishikawa H; Uehara Y; Ogawa M; Saku K
JCS 73th Annual Scientific Meeting., 2009年03月21日

Characterization of plasma lipoprotein abnormality in WHHLMI rabbits using capillary isotachophoresis in combination with quantitative ultracentrifugation.
Zhang B; Shiomi M; Saku K
第３回 ウサギフォーラム., 2008年07月26日

キャピラリー等速電気泳動法によるリポ蛋白分析と臨床応用.
張波
南東京動脈硬化フォーラム., 2008年04月08日

Comparison of LDL subclasses as analyzed by quantitative ultracentrifugation, nuclear magnetic resonance spectroscopy and capillary isotachophoresis.
Zhang B; Matsunaga A; Noda K; Miura SI; Hattori H; Nishikawa H; Saku K
JCS 72th Annual Scientific Meeting., 2008年03月29日

Fast-migrating low-density lipoprotein as analyzed by capillary isotachophoresis is related to inflammatory markers and reduced by pravastatin and simvastatin: the SPECIAL study.
Zhang B; Miura SI; Noda K; Nishikawa H; Matsunaga A; Shirai K; Iwata A; Keijiro S
ACC2008., 2008年03月21日

リポ蛋白分析のトピックス-キャピラリー等速電気泳動（capillary IsoTachoPhoresis: cITP）によるリポ蛋白分析.
張波
若手脂質研究者の集い., 2007年11月24日

Novel technology for comprehensive analyses of oxidative stress biomarkers.
張波
HPLCｶﾗﾑﾕｰｻﾞｰｽﾞﾐｰﾃｨﾝｸﾞ., 2007年10月23日

Effects of Low-dose Rosuvastatin on Charge-Modified LDL as Characterized by Capillary Isotachophoresis (ROSARY).
Zhang B; Matsunaga A; Noda K; Miura SI; Nishikawa H; Saku K
JAS 39th Annual Scientific Meeting., 2007年07月14日

ApoA-I/phosphatidylcholine discs reduce charge-modified LDL as characterized by capillary isotachophoresis.
Zhang B; Uehara Y; Hida S; Miura SI; Kumagai K; Rye K-A; Saku K
JCS 71th Annual Scientific Meeting., 2007年03月17日

Effects of simvastatin and pravastatin on charge-based LDL subfractions in patients with hypercholesterolemia as determined by capillary isotachophoresis (PSCI-Study).
Zhang B; Keita N; Nishikawa H; Saku K
JAS 38th Annual Scientific Meeting., 2006年07月13日

In vitro incubation of ETC-642 discs: potential remoldeling of HDL subfractions as characterized by capillary isotachophoresis.
Zhang B; Uehara Y; Miura SI; Keijiro S
The XIVth ISH., 2006年06月22日

Plasma and urine sample preparation using multidimensional solid-phase extraction for analysis of F2 isoprostanes by LC-MS/MS.
Zhang B; Keijiro S
The XIVth ISH., 2006年06月22日

Association between fast-migrating low-density lipoprotein subfraction as characterized by capillary isotachophoresis and intima-media thickness of carotid artery.
Zhang B; Hayashi J; Saku K
JCS 70th Annual Scientific Meeting., 2006年03月24日

Role of electronegative LDL in experimental lipoprotein glomerulopathy (LPG).
Atsunori Ishimura; Bo Zhang; Yoshito Miyahara; Satoru Ogahara; Yasushi Ishigaki; Hideo Shimura; Hidetoshi Kaneoka; Keiji Saku; Takao Saito
3rd Congress of Nephrology, 2005年06月27日

Relation between remnant-like particle fraction and electronegative low-density lipoprotein subfraction in patients with hypercholesterolemia.
Zhang B; Imaizumi S; Noda K; Matsunaga A; Saku K
JCS 69th Annual Scientific Meeting., 2005年03月21日

Detection and quantification of potentially atherogenic triglyceride-rich remnant lipoprotein subfraction using capillary isotachophoresis.
Zhang B; Imaizumi S; Noda K; Matsunaga A; Saku K
JCS 69th Annual Scientific Meeting., 2005年03月19日

Reconstituted high-density lipoprotein (HDL) converts plasma fast-migrating HDL into slow-migrating HDL and favorably affects the size distribution of HDL.
Zhang B; Miura SI; Rye K-A; Saku K
JCS 69th Annual Scientific Meeting., 2005年03月19日

Charge-based major low-density lipoprotein subfraction associated with Alzheimer's disease and mild cognitive impairment.
Zhang B; Nakano S; Akira M; Tatsuo Y; Keijiro S
ACC2005., 2005年03月06日

Association between electronegative low-density lipoprotein subfraction and insulin resistance in non-diabetic children.
Zhang B; Kaneshi T; Ohta T; Keijiro S
ACC2005., 2005年03月06日

In animal model of lipoprotein glomerulopathy induced by apolipoprotein E (ApoE)-Sendai
Atsunori Ishimura; Yoshito Miyahara; Bo Zhang; Satoru Ogahara; Hidetoshi Kaneoka; Keijiro Saku; Takao Saito
37th Annual Meeting of the American Society of Nephrology, 2004年10月29日

Reduced electronegative LDL (enLDL) and improved cyclosporine A (CyA) absorption by LDL-apheresis (LDL-A) in refractory nephrotic syndrome
Satoru Ogahara; Bo Zhang; Yasuhiro Abe; Toshiaki Murata; Yoshie Sasatomi; Hidetoshi Kaneoka; Keijiro Saku; Takao Saito
37th Annual Meeting of the American Society of Nephrology, 2004年10月29日

A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia.
Zhang B; Noda K; Matsunaga A; Keijiro S
DALM XV International Symposium., 2004年10月26日

Liver x receptor α (LXRα) mRNA levels induced by pitavastatin in HepG2 cells.
Zhang B; Fan P; Keijiro S
DALM XV International Symposium., 2004年10月26日

Inhibition of CETP activity by JTT-705 increases apoE-containing HDL and favorably affects the function and enzymatic composition of HDL in rabbits.
Zhang B; Fan P; Shimoji E; Bian C; Keijiro S
HDL Workshop 2004., 2004年09月04日

Effects of cholesterol on platelet-activating factor acetylhydrolase activity, paraoxonase activity, and lysophosphatidylcholine concentration.
Zhang B; Shimoji E; Fan P; Keijiro S
JCS 68th Annual Scientific Meeting., 2004年03月29日

Modulating effects of cholesterol elevation by diet-feeding and cholesterol lowering by simvastatin on platelet-activating factor acetylhydrolase activity, paraoxonase activity, and lysophosphatidylcholine concentration.
Zhang B; Shimoji E; Fan P; Keijiro S
ACC2004., 2004年03月08日

Metabolic background modulates the effects of cholesteryl ester transfer protein inhibition (CETP) on the catabolism, function, and composition of high density lipoprotein (HDL) particle.
Zhang B; Shimoji E; Fan P; Keijiro S
AHA 76th Scientific Session., 2003年11月14日

Quick and sensitive mornitoring of oxidatively modified low density lipoprtoein (LDL) subfractions by capillary isotachophoresis (cITP).
Zhang B; Keijiro S
The XIIIth ISA., 2003年10月02日

Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods.
Zhang B; Shimoji E; Keijiro S
The XIIIth ISA., 2003年10月01日

Rapid detection of uncoupling protein 2 -866G/A mutation by mutagenically separated polymerase chain reaction (MS-PCR).
Zhang B; Hiroaki T; Keijiro S
The XIIIth ISA., 2003年09月30日

Inhibition of cholesteryl ester transfer protein (CETP) activity increases paraoxonase (PON1) activity toward paraoxon and decreases plasma lysophosphatidylcholine (LysoPC) levels.
Zhang B; Fan P; Shimoji E; Keijiro S
The XIIIth ISA., 2003年09月29日

Decreased Activities of Paraoxonase and High-Density-Lipoprotein-Associated Platelet Activating Factor Acetylhydrolase in Hemodialysis Patients.
Zhang B; Fan P; Satoshi E; Shimoji E; Keijiro S
ACC 52th Annual Scientific Session., 2003年03月19日

高HDL・高LDL血漿患者におけるキャピラリー等速電気泳動(cITP)法によるリポ蛋白分画の特徴.
張波, 范平; 辺城; 下地栄壮; 朔啓二郎
第34回日本動脈硬化学会総会., 2002年07月19日

A cholesteryl ester transfer protein (CETP) inhibitorincreased in vivo synthetic rates and liver mRNA levels of apolipoprotein A-I.
Shimoji E; Zhang B; Fan P; Keijiro S
ACC 51st Annual Scientific Session., 2002年03月06日

A cholesteryl ester transfer protein (CETP) inhibitor, JTT-705, increases platelet-activating factor acetylhydrolase (PAF-AH).
Zhang B; Shimoji E; Fan P; Mei J; Keijiro S
DALM 14th International Symposium., 2001年09月10日

Serum levels of HDL-C modify the risk of coronary artery disease (CAD) associated with cigarette smoking in men.
Zhang B; Takezako T; Shimoji E; Kitajima K; Keijiro S
10th International Congress of Cardiovascular Pharmacotherapy., 2001年03月27日

Serum HDL-C levels modulate the effects of a polymorphism of the cholesterol ester transfer protein (CETP) gene on the risk of coronary heart disease (CHD).
Zhang B; Fan P; Kumagai K; Saku K
AHA 73rd Scientific Sessions., 2000年11月14日

Receiver Operating Characteristic (ROC)曲線解析法による、血清Lp(a)値とアポ(a)イソ蛋白多型の冠動脈硬化症(CHD)への診断精度の検討.
張波, 范平; 土屋芳弘; 白井和之; 朔啓二郎
第32回日本動脈硬化学会総会., 2000年06月01日

精神遅滞を合併した、LCAT機能異常としての魚眼病の1症例ーリポ蛋白分析と遺伝子解析について.
張波; 自見至郎; von Eckardstein Henri; Molhuizen Henri O.F; 范 平; 朔啓二郎
第32回日本動脈硬化学会総会., 2000年06月01日

HDLの量（血清HDL-C値）とHDL機能指標（HDL分画でのコレステロール化率：FERHDL）と、冠動脈硬化症（CHD）の関連、年齢、性差、肥満度の重要性.
張波; 朔 啓二郎; 白井和之; 土屋芳弘; 田代英一郎; 荒川規矩男
第64回日本循環器学会., 2000年04月02日

The association of FERHDL with gender, age, body mass index, and coronary artery disease (CAD).
Zhang B; Saku K; Shirai K; Takao M; Arakawa K
ACC 49th Annual Scientific Session., 2000年03月14日

Receiver operating characteristic (ROC) curve analysis of the ability of apolipoprotein(a) isoform polymorphism and serum lipoprotein(a) levels to predict the risk of CHD in men.
Zhang B; Saku K; Arakawa K
ACC 49th Annual Scientific Session., 2000年03月14日

Hyperinsulinemic hypoalphalipoproteinemiaは、冠動脈硬化症の新しい診断指標になりうる.
張波; 朔 啓二郎; 白井 和之; 竹迫 大伸; 荒川 規矩男
第63回日本循環器学会., 1999年03月27日

Receiver-operator characteristic curve解析法を用いた、Lp(a), HDL-C, apo(a) phenotypes と心臓病の関連.
張波; 朔啓二郎; 荒川規矩男
第3回Lp(a) カンファレンス., 1998年12月12日

High dose troglitazone投与の血糖及びインスリン代謝に及ぼす効果：WHHL ウサギでの検討.
張波; 朔啓二郎; 塩見雅志; 辻田代史雄; 堀越大能; 荒川規矩男
第30回日本動脈硬化学会（総会）., 1998年06月12日

冠動脈硬化症患者におけるアンジオテンシンIIタイプ1受容体遺伝子A/C1166多型と高血圧の関連.
張波; 朔啓二郎; 欧加福; 白懐; 白井和之; 岡部眞典; 荒川規矩男
第30回日本動脈硬化学会（総会）., 1998年06月12日

本態性高血圧症患者におけるβ１選択性β遮断薬及びCa拮抗薬の血清リポ蛋白、アポ蛋白値に及ぼす影響.
張波; 朔啓二郎; 荒川規矩男
平成9年度日本動脈硬化学会（冬季大会）., 1997年11月27日

アンジオテンシンII受容体拮抗薬ーCS866の血圧、糖、脂質代謝に及ぼす影響.
張波; 朔啓二郎; 劉瑞, 劉侃; 武田由紀子; 荒川規矩男
平成８年度日本動脈硬化学会（冬期学会）., 1996年11月28日

Troglitazone, a drug for insulin resistance, reduces blood pressure in WHHL rabbits.
Zhang B; Saku K; Jimi S; Liu R; Takeda Y; Liu K; Takebayashi S; Arakawa K
ISH 16th Scientific Meeting., 1996年06月26日

LDL及びVLDL除去後血清でのコレステロールエステル化率と冠動脈硬化症.
張波; 朔啓二郎; 劉瑞; 自見至郎; 太田孝男; 竹林茂男; 荒川規矩男
第28回日本動脈硬化学会（総会)., 1996年06月14日

数学モデル解析によるtroglitazoneのインスリン感受性に及ぼす効果?WHHL家兎での検討.
張波; 朔啓二郎; 自見至郎; 劉瑞; 平田恭子; 白懐; 竹林茂夫; 荒川規矩男
平成７年度日本動脈硬化学会（冬期学会）., 1995年11月25日

CS-045によるｲﾝｽﾘﾝ抵抗性の改善は動脈硬化進展に防御的か？WHHL家兎での検討.
張波; 自見至郎; 朔啓二郎; 竹林茂夫; 荒川規矩男
平成６年度日本動脈硬化学会（冬期学会）., 1994年11月11日

Effects of CS-045 on insulin resistance in WHHL rabbits.
Zhang B; Saku K; Hirata K; Liu R; Sasaki N; Arakawa K
The 2nd International Symposium on Multiple Risk Factors in Cardiovascular Disease., 1992年10月06日

ウサギにおける経静脈ブドウ糖負荷試験(IVGTT) 第３報：ACE阻害薬（シラザプリル）の効果.
張波; 朔啓二郎; 平田恭子; 劉瑞; 大倉義文; 紅英; 荒川規矩男
第24回日本動脈硬化学会（総会）., 1992年06月20日

Insulin resistance observed in WHHL rabbits and effects of cilazapril.
Zhang B; Saku K; Hirata K; Liu R; Nomoto J; Ying H; Arakawa K
DALM XI International Symposium., 1992年05月14日

ウサギにおける経静脈ブドウ糖負荷試験(IVGTT, 第２報：コレステロール負荷ウサギとWHHLウサギの差異.
張波; 朔啓二郎; 平田恭子; 劉瑞; 大倉義文; 紅英; 荒川規矩男
平成３年度日本動脈硬化学会 （冬季大会）., 1992年04月22日

ウサギにおける経静脈ブドウ糖負荷試験第１報：WHHLウサギでの検討.
張波; 平田恭子; 劉瑞, 紅英; 大倉義文; 朔啓二郎; 山本匡介; 荒川規矩男
平成３年度日本動脈硬化学会 （冬季大会）., 1991年12月06日